Skip to main content
Premium Trial:

Request an Annual Quote

Suregene Receives NIH Grant to Develop Schizophrenia Test

NEW YORK (GenomeWeb News) – Suregene said last week that it has received a $497,000 grant from the National Institute of Mental Health to develop a test for the early detection of schizophrenia.

According to the company, the test focuses on two genetic variations observed in some patients with the mental disorder. The company hopes the test will allow physicians to gauge the risk of a patient developing schizophrenia, as well as help with the development of personalized therapies.

The grant, Suregene said, will also support research into the genetics of bipolar disorder and the development of a second-generation test that incorporates novel genetic biomarkers for schizophrenia susceptibility.

 

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.